Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mind Medicine (MindMed) Inc. - Common Shares
(NQ:
MNMD
)
7.200
+0.030 (+0.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mind Medicine (MindMed) Inc. - Common Shares
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
33
34
Next >
Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today
April 21, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 20.83% at $0.29
Via
Benzinga
Why MindMed’s LSD Trial for Anxiety May Be Important to Psychedelic Investors
April 21, 2022
Via
Investor Brand Network
Psychedelic Stock Gainers And Losers From April 20, 2022
April 20, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.69% at $0.16 LOSERS:
Via
Benzinga
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
April 19, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.57% at $0.33
Via
Benzinga
EXCLUSIVE: Breaking Down Public Vs. Private Psychedelic Investments
April 19, 2022
For many private companies, the goal is clear: to go public. For others, the goal is an acquisition. Either way, private companies offer attractive potential for investors, especially in emerging...
Via
Benzinga
EXCLUSIVE: Why Kevin O'Leary Of 'Shark Tank' Says Public Psychedelics Companies Will Need To Merge
April 19, 2022
The market opportunity for legal psychedelics is in the hundreds of billions of dollars, “Shark Tank” judge Kevin O’Leary told the inaugural Benzinga Psychedelics Capital Conference on Tuesday.
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 18, 2022
April 18, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.66% at $0.28
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 14, 2022
April 14, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 2.50% at $5.32
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 13, 2022
April 13, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.41% at $0.24
Via
Benzinga
Numinus Wellness Strives To Become Psychedelic Research Hub After Acquisition Of Novamind Inc.
April 13, 2022
In a year where M&A activity is expected to ratchet-up in 2022, Numinus Wellness Inc. (OTC: NUMIF) is among the first to take action.
Via
Benzinga
Why Psychedelics Could Soon Replace Antidepressants
April 13, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 13, 2022 – Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults...
Via
FinancialNewsMedia
Psychedelic Stock Gainers And Losers From April 11, 2022
April 11, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.52% at $0.17
Via
Benzinga
Revive Therapeutics, Cybin Among Top Psychedelic Movers Of Today
April 08, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.54% at $0.16
Via
Benzinga
Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today
April 07, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.48% at $0.14
Via
Benzinga
Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today
April 06, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 4.78% at $19.73 LOSERS:
Via
Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
April 06, 2022
It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector.
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 5, 2022
April 05, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 1.60% at $1.27 LOSERS:
Via
Benzinga
MindMed Appoints Francois Lilienthal As New CCO
April 05, 2022
With over twenty years of experience in the biopharmaceutical industry, Francois Lilienthal, MD, has joined Mind Medicine Inc. ...
Via
Benzinga
From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers
April 04, 2022
With over ten years of experience in the pharmaceutical industry, Robert Barrow, CEO of Mind Medicine Inc. (NASDAQ: MNMD) is someone ...
Via
Benzinga
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
April 04, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.06% at $14.18
Via
Benzinga
Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity?
April 04, 2022
Long gone is the heyday of investor enthusiasm and easy access to capital that marked the launch of the psychedelics industry into the public markets. In recent months, psychedelics stocks entered into...
Via
Benzinga
3 Psychedelic Stocks to Buy for Oregon’s Magic Mushroom Bill
April 04, 2022
Psychedelic medical treatments and therapies are gaining in popularity, and these psychedelic stocks could benefit as the market emerges.
Via
InvestorPlace
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
April 01, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.26% at $0.86
Via
Benzinga
March Update: Psychedelic Compounds-Based Drug Stocks Index Went Down -19%
April 01, 2022
An update on the revisions that have been made to the Pure-Play Psychedelic Compounds-Based Drug Stocks Index with the increase in the minimum market capitalization required to be included in the...
Via
Talk Markets
Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today
March 31, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.38% at $0.27
Via
Benzinga
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
March 30, 2022
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 4.22% at $0.46
Via
Benzinga
Demand for Toad Venom Rises Along With the Booming Psychedelics Market
March 30, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 30, 2022 – Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic...
Via
FinancialNewsMedia
Psychedelic Stock Gainers And Losers From March 29, 2022
March 29, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 9.05% at $5.42
Via
Benzinga
Psyched: Third Michigan City Decriminalizes Psychedelics, MindMed Reports $133M Cash Position, Real Brands To Enter The Space
March 29, 2022
The psychedelics legislative landscape continues to move forward with Hazel Park,Michiganenacting decriminalization ...
Via
Benzinga
Mindset Pharma, Small Pharma Among Top Psychedelic Movers Of Today
March 28, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 8.24% at $0.18
Via
Benzinga
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
33
34
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.